Jackson Wealth Management LLC Raises Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Jackson Wealth Management LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 21.4% in the 3rd quarter, Holdings Channel reports. The firm owned 788 shares of the healthcare conglomerate’s stock after purchasing an additional 139 shares during the period. Jackson Wealth Management LLC’s holdings in UnitedHealth Group were worth $461,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in UNH. Delta Financial Group Inc. increased its stake in UnitedHealth Group by 1.0% in the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after purchasing an additional 17 shares during the last quarter. Signature Resources Capital Management LLC increased its stake in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares during the last quarter. Saxony Capital Management LLC increased its stake in UnitedHealth Group by 3.5% during the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after acquiring an additional 18 shares during the last quarter. GoalVest Advisory LLC boosted its position in shares of UnitedHealth Group by 0.6% in the second quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock worth $1,591,000 after buying an additional 18 shares during the period. Finally, Fiduciary Group LLC boosted its position in shares of UnitedHealth Group by 0.5% in the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after buying an additional 18 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 0.7 %

Shares of UNH stock opened at $560.82 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The stock has a market cap of $517.87 billion, a PE ratio of 36.54, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58. The business’s fifty day moving average is $584.16 and its 200-day moving average is $536.49. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period last year, the firm earned $6.56 EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.50%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on UNH. Bank of America decreased their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and upped their target price for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. UBS Group reduced their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Robert W. Baird increased their price target on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Finally, Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.